Award details

Quantitative investigations into the molecular mechanisms of amyloid fibril fragmentation

Reference	BB/J008001/1
Principal Investigator / Supervisor	Dr Wei-Feng Xue
Co-Investigators / Co-Supervisors
Institution	University of Kent
Department	Sch of Biosciences
Funding type	Research
Value (£)	408,850
Status	Completed
Type	Research Grant
Start date	01/06/2012
End date	31/05/2015
Duration	36 months

Abstract

In order to characterise the molecular mechanisms of amyloid fibril fragmentation, to quantify the rates of fibril fragmentation, and to determine the influence of fragmentation on cellular processes, a combination of experimental, theoretical and computational approaches will be employed. The fibril fragmentation properties of three amyloid models: the yeast prion protein Sup35, human alpha-synuclein, and hen egg white lysozyme, representing a functional, a disease-related and an artificial model system, respectively, will be examined. Firstly, their fibril stability towards fragmentation will be characterised using tapping-mode atomic force microscopy. Image data collected during fragmentation facilitated by stirring will be analysed through the application of statistical image analysis methods in order to quantify changes in fibril dimensions. Secondly, models of how fibril fragmentation might occur will be developed and computer simulations of fragmentation processes will be performed in parallel with the experiments. Modelling strategies, through a systems approach with large-scale population balance simulations will be developed to tackle the complexities of heterogeneous mixture of species involved in fibril fragmentation. Potential models will be quantitatively tested against the data using regression and model comparison methods to delineate models that can describe and predict fibril fragmentation. Thirdly, the in vitro measurements of fragmentation properties will be applied to the quantitative characterisation of the biological consequence of Sup35 fibril fragmentation in yeast cells. How changes in the fragmentation properties of Sup35 fibrils affect the resulting [PSI+] prion phenotype in vivo will be accessed using mutants of Sup35. This application of quantitative fibril fragmentation analysis will test the hypothesis that enzyme controlled fibril fragmentation is an integral part of functional amyloid in biology.

Summary

Amyloid fibrils are forms of protein that have received much recent attention through their association with numerous devastating human brain diseases. Examples include Alzheimer, Creutzfeldt-Jakob (CJD), Huntington and Parkinson diseases. Furthermore, the unusual physical characteristics of amyloid fibrils mean that they have the potential to become strong and stable engineered nanomaterials. Breaking amyloid fibrils into smaller pieces is a key process that must be fully understood if we are to understand how amyloid fibrils normally function in nature, and how they are involved in diseases so we can develop effective therapies against the amyloid-associated diseases. Nevertheless, the causes and consequences of amyloid fibril fragmentation remain a largely unexplored area of research. The long-term goal of this project is to resolve the molecular and cellular mechanisms of fibril fragmentation. Amyloid fibrils are assembled from whole or parts of normal proteins and the devastating human diseases associated with amyloid are linked to the way the amyloid fibrils are assembled and deposited in the brain or in other parts of the human body. However, amyloid fibrils have also been recognised as a class of natural protein forms, so-called 'functional amyloids'. Functional amyloids can play a number of important roles in bacteria, yeast and even humans. A sub-class of amyloids can spread between organisms by forming small seeds through the fragmentation of larger fibrils. This sub-class is referred to as prions and they exist in humans where they cause diseases such as CJD. In baker's yeast, they confer special cellular properties on the cells that are passed on from generation to generation; a form of 'protein gene'. To fully understand how prions are formed and transmitted requires that we understand how the prion seeds (which we call propagons) are generated through amyloid fibril fragmentation. Detailed characterisation of amyloid fibrils of different origins hasrevealed incredibly strong structures that are commonly only tens of nanometres thick but many micrometers long. The fragmentation property of amyloid fibrils is, however, the dominating factor for their stability. Fibril fragmentation is also an important factor in amyloid-associated disease because it influences the size and shape of the disease-associated forms of the fibrils, which are typically large clumps of aggregates. How easy do disease-associated prions spread, how fast are amyloid aggregates assembled and deposited, and how toxic are these aggregates to cells are important disease properties that are influenced by amyloid fibril fragmentation. To address these points, our goal is to answer the following questions: how are amyloid fibrils fragmented, how fast can they fragment, and how is fragmentation linked to their properties in living cells. Using a combination of experimental, theoretical and computational approaches, the fragmentation properties of three different amyloids will be studied: one that forms a prion in yeast, one that is associated with human disease, and the third is an artificial model system. The insights gained from this project will also be critical for further exploring amyloid fibrils as potential nanomaterial in technological applications, and will provide new insights that will facilitate the future development of therapeutic strategies against amyloid associated disease.

Impact Summary

The findings of this proposed project will not only benefit researchers exploring the basic mechanisms of amyloid formation or prion propagation, they will likely have a number of important applications. Using amyloid fibrils in novel bio-nanomaterials, and developing therapies targeting amyloid disease are examples of the many potential applications of the findings of this project. These potential applications will revolutionise a variety of industries in the medical, tele-communication and manufacturing sectors, as well as improve life in general in an aging population. In addition, this project will provide a postdoctoral researcher with an unique training opportunity. The postdoctoral scientist will develop skills to apply mathematics, chemistry and physics methods to solve important biological problems, and learn to communicate ideas across disciplinary boundaries. The findings of this project will be of interest to a wide group of researchers in diverse disciplines through the means of publications in open access multidisciplinary peer-reviewed journals and presentations in international conferences covering topics ranging from biology, physics, chemistry to material science. Any potential commercial applications arising from this proposal will be explored with the help and support from the Kent Innovation and Enterprise business development unit within the University of Kent.

Committee	Research Committee D (Molecules, cells and industrial biotechnology)
Research Topics	Microbiology, Structural Biology, Systems Biology
Research Priority	Nanotechnology, Systems Approach to Biological research
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search